Sight Sciences, a medtech company based in California, specializes in devices to treat glaucoma and dry eye disease. The company has recently announced FDA 510(k) clearance for the TearCare System, a device designed to treat meibomian gland dysfunction.
Meibomian glands are present near the rims of our eyelids and they secrete a clear oily (Read more...)